Pabrik China CAS: 204255-11-8.

Humanwell Pharmaceutical minangka salah sawijining pabrik API paling gedhe ing China. Kanthi luwih saka 20 taun pengalaman, kita berkembang, Pabrik lan perdagangan API steroid, intermediet lan formulasi. Pasar kita kalebu ing saindenging jagad, kita duwe kehadiran sing kuat ing Amerika Utara, Eropa, Amerika Selatan lan Afrika, kanthi produk sing didol menyang luwih saka 150 negara.

Produk Panas

  • 21-acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione

    21-acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione

    21-Acetoxy-11β-hydroxypregna-1,4,16-triene-3,20-dione minangka perantara ing sintesis turunan sing gegandhengan karo Budesonide (B689490).

    CAS: 3044-42-6

  • 16alpha-Hydroxyprednisolone

    16alpha-Hydroxyprednisolone

    16alpha-Hydroxyprednisolone duwe DMF kasedhiya.

    CAS: 13951-70-7

  • 16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate digunakake kanggo mirsani interaksi sawetara obatan steroid karo β-cyclodextrin polymer kanggo ngetung kekuatan relatif saka interaksi antarane paramèter hydrophobicity saka obatan lan kekuatan saka tamba-β-âpolimer cyclodextrin.

    CAS: 86401-80-1

  • Abiraterone

    Abiraterone

    Abiraterone minangka inhibitor sitokrom steroid P 450 17α-hydroxylase-17,20-lyase (CYP17), digunakake ing kombinasi karo prednison kanggo nambani pasien kanker prostat sing tahan kastrasi metastatik (kanker prostat sing tahan kanggo perawatan medis utawa bedah. testosteron sing luwih murah lan wis nyebar menyang bagean awak liyane) lan kanker prostat sing sensitif castration-resiko metastatik.

    CAS: 154229-19-3

  • Eslicarbazepine Acetate

    Eslicarbazepine Acetate

    Eslicarbazepine Acetate nduweni spesifikasi In-house. DMF disetujoni.

    CAS: 236395-14-5

  • Triasetil-gansiklovir

    Triasetil-gansiklovir

    Triacetyl-ganciclovir minangka turunan Ganciclovir.

    CAS: 86357-14-4

Kirim Pitakonan

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept